Biotechnology
The Biotechnology industry has a total of 603 stocks, with a combined market cap of $1.13 trillion and total revenue of $105.41 billion.
Market Cap
1.13T
Revenue
105.41B
Profits
-41.55B
PE Ratio
n/a
Profit Margin
-39.42%
Dividend Yield
0.04%
603 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.49B | 2.24% | 160,176 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 82.35B | 3.36% | 189,031 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 56.16B | 4.61% | 190,384 | 3.21B |
| 4 | ARGX | argenx SE | 49.07B | 2.24% | 125,962 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.71B | 0.99% | 188,320 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 36.96B | 4.26% | 103,646 | 4.97B |
| 7 | RPRX | Royalty Pharma plc | 23.75B | 1.23% | 582,139 | 2.35B |
| 8 | BNTX | BioNTech SE | 23.71B | 0.53% | 124,137 | 3.70B |
| 9 | INCY | Incyte Corporation | 21.67B | 3.51% | 495,600 | 4.81B |
| 10 | GMAB | Genmab A/S | 20.39B | 2.42% | 573,471 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.89B | 2.93% | 337,461 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.99B | -0.23% | 761,631 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.47B | 0.54% | 262,783 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.47B | 1.46% | 169,993 | 353.78M |
| 15 | MRNA | Moderna, Inc. | 13.95B | 0.08% | 2,066,222 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.83B | 4.80% | 549,458 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 13.25B | 3.17% | 64,063 | 758.59M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.13B | 3.60% | 47,131 | 740.64M |
| 19 | EXEL | Exelixis, Inc. | 12.15B | 3.34% | 233,481 | 2.29B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.71B | 1.45% | 161,497 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | 0.11% | 194,997 | 20.87M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.39B | 2.38% | 210,530 | 4.16B |
| 23 | TECH | Bio-Techne Corporation | 10.14B | -0.32% | 94,168 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.41B | 4.01% | 399,929 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.96B | -6.88% | 1,050,628 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.71B | 0.57% | 25,680 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.68B | 0.89% | 462,180 | 1.24B |
| 28 | CAI | Caris Life Sciences, Inc. | 8.14B | 1.62% | 195,338 | 649.06M |
| 29 | CYTK | Cytokinetics, Incorporated | 8.07B | 2.21% | 173,107 | 87.21M |
| 30 | NUVL | Nuvalent, Inc. | 7.86B | 4.13% | 31,063 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 7.37B | 1.97% | 5 | 373.16M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.26B | 6.38% | 309,709 | 7.46M |
| 33 | CDTX | Cidara Therapeutics, Inc. | 6.97B | - | - | 302.00K |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.69B | 0.89% | 37,079 | 174.33M |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.32B | 2.58% | 211,567 | 1.78B |
| 36 | KYMR | Kymera Therapeutics, Inc. | 6.08B | 3.43% | 83,999 | 43.74M |
| 37 | BLTE | Belite Bio, Inc | 6.04B | 0.51% | 33,685 | - |
| 38 | PCVX | Vaxcyte, Inc. | 6.02B | 2.50% | 192,518 | - |
| 39 | CRSP | CRISPR Therapeutics AG | 5.62B | 1.39% | 233,035 | 38.34M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.44B | 2.76% | 360,931 | - |
| 41 | IMVT | Immunovant, Inc. | 5.42B | 3.17% | 237,995 | - |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.28B | 0.07% | 55,253 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.11B | -0.69% | 61,055 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.98B | 2.41% | 46,210 | - |
| 45 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.95B | 13.61% | 900,250 | 1.54M |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.66B | 2.15% | 100,214 | 1.05B |
| 47 | GPCR | Structure Therapeutics Inc. | 4.59B | 5.08% | 8,023 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.43B | 5.23% | 111,735 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.42B | -0.04% | 798,535 | 598.70M |
| 50 | ADMA | ADMA Biologics, Inc. | 4.39B | 0.60% | 151,623 | 488.56M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.36B | 1.33% | 185,246 | 531.90M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.26B | 2.27% | 80,839 | - |
| 53 | LEGN | Legend Biotech Corporation | 4.06B | 4.67% | 308,011 | 909.05M |
| 54 | MIRM | Mirum Pharmaceuticals, Inc. | 4.04B | 2.28% | 34,698 | 471.79M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.02B | 4.09% | 46,937 | 35.24M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.93B | 1.78% | 10,952 | 251.23M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.86B | 2.49% | 262,322 | 741.17M |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.70B | 3.49% | 264,551 | 317.93M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.65B | -0.12% | 568,731 | - |
| 60 | ACLX | Arcellx, Inc. | 3.63B | 1.16% | 49,518 | 35.90M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.44B | 4.30% | 134,779 | - |
| 62 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | 1.04% | 28,015 | 366.10M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.39B | 2.29% | 115,631 | 15.00M |
| 64 | CGON | CG Oncology, Inc. | 3.39B | 4.04% | 65,175 | 2.17M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.32B | 3.66% | 192,059 | 435.83M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.28B | 3.17% | 87,261 | 214.83M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.24B | 2.24% | 152,442 | 7.50M |
| 68 | APLS | Apellis Pharmaceuticals, Inc. | 3.21B | 5.93% | 282,196 | 1.02B |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.09B | 3.48% | 191,908 | - |
| 70 | NUVB | Nuvation Bio Inc. | 3.01B | 3.42% | 423,993 | 26.75M |
| 71 | IRON | Disc Medicine, Inc. | 3.00B | 2.77% | 24,155 | - |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.95B | 0.65% | 84,382 | 70.79M |
| 73 | MLYS | Mineralys Therapeutics, Inc. | 2.92B | 3.47% | 107,101 | - |
| 74 | BEAM | Beam Therapeutics Inc. | 2.88B | 3.00% | 207,860 | 55.70M |
| 75 | WVE | Wave Life Sciences Ltd. | 2.87B | 3.60% | 870,135 | 109.23M |
| 76 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | 2.79% | 109,688 | 578.20M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.83B | 5.30% | 75,775 | 240.00M |
| 78 | DNLI | Denali Therapeutics Inc. | 2.77B | 3.02% | 186,731 | - |
| 79 | LQDA | Liquidia Corporation | 2.68B | 0.26% | 146,536 | 69.22M |
| 80 | AAPG | Ascentage Pharma Group International | 2.64B | 8.30% | 6,055 | 54.52M |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.54B | 4.66% | 45,021 | - |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.54B | 3.29% | 171,598 | 252.75M |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.51B | 0.27% | 25,048 | 664.23M |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.49B | 0.35% | 144,381 | 98.68M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.45B | 3.30% | 4,515,661 | 43.69M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.44B | 1.60% | 310,822 | 55.78M |
| 87 | SYRE | Spyre Therapeutics, Inc. | 2.43B | 3.43% | 74,702 | - |
| 88 | MESO | Mesoblast Limited | 2.36B | 0.32% | 11,888 | 17.20M |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.36B | 0.63% | 240,751 | 2.41B |
| 90 | IMNM | Immunome, Inc. | 2.27B | 4.10% | 156,057 | 9.68M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | 3.37% | 293,610 | 630.60M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | 2.99% | 37,905 | 825.94M |
| 93 | GLPG | Galapagos NV | 2.15B | 1.11% | 15,762 | 336.64M |
| 94 | IBRX | ImmunityBio, Inc. | 2.15B | 1.87% | 1,707,082 | 82.56M |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.12B | 5.17% | 131,841 | 205.63M |
| 96 | ZLAB | Zai Lab Limited | 2.11B | 4.40% | 162,441 | 441.63M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 1.88% | 151,053 | 265.81M |
| 98 | OLMA | Olema Pharmaceuticals, Inc. | 2.06B | 4.83% | 316,729 | - |
| 99 | VCEL | Vericel Corporation | 2.06B | 3.58% | 76,978 | 258.72M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.90B | 2.97% | 43,325 | 2.50M |
| 101 | ZYME | Zymeworks Inc. | 1.85B | 2.36% | 209,405 | 134.48M |
| 102 | ALMS | Alumis Inc. | 1.84B | 8.50% | 2,552,787 | 22.12M |
| 103 | CLDX | Celldex Therapeutics, Inc. | 1.83B | 4.98% | 66,999 | 2.60M |
| 104 | NRIX | Nurix Therapeutics, Inc. | 1.82B | 2.98% | 127,665 | 83.69M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 1.87% | 204,972 | 111.30M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.78B | 7.23% | 36,214 | - |
| 107 | MNKD | MannKind Corporation | 1.77B | 2.58% | 249,253 | 313.79M |
| 108 | IMCR | Immunocore Holdings plc | 1.77B | 6.54% | 88,153 | 379.59M |
| 109 | PGEN | Precigen, Inc. | 1.69B | 5.05% | 768,390 | 6.31M |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 4.73% | 71,220 | 44.79M |
| 111 | DNTH | Dianthus Therapeutics, Inc. | 1.67B | 7.73% | 86,901 | 3.08M |
| 112 | KOD | Kodiak Sciences Inc. | 1.67B | 9.38% | 155,623 | - |
| 113 | PHVS | Pharvaris N.V. | 1.64B | 5.16% | 36,489 | - |
| 114 | FTRE | Fortrea Holdings Inc. | 1.64B | 1.25% | 73,162 | 2.76B |
| 115 | GLUE | Monte Rosa Therapeutics, Inc. | 1.56B | 49.97% | 13,347,669 | 181.54M |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 1.51B | 5.13% | 277,986 | 6.31M |
| 117 | EYPT | EyePoint, Inc. | 1.50B | 7.47% | 163,111 | 42.34M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.50B | 6.44% | 48,714 | - |
| 119 | RLAY | Relay Therapeutics, Inc. | 1.49B | 5.02% | 250,947 | 8.36M |
| 120 | UPB | Upstream Bio, Inc. | 1.47B | 5.14% | 30,261 | 2.80M |
| 121 | INVA | Innoviva, Inc. | 1.47B | 1.61% | 40,509 | 388.52M |
| 122 | QURE | uniQure N.V. | 1.47B | 5.47% | 116,821 | 15.75M |
| 123 | ARDX | Ardelyx, Inc. | 1.46B | 8.18% | 1,323,525 | 398.23M |
| 124 | MBX | MBX Biosciences, Inc. | 1.45B | 12.65% | 158,913 | - |
| 125 | ATAI | AtaiBeckley Inc. | 1.45B | -0.25% | 342,126 | 3.02M |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.44B | 2.00% | 233,576 | - |
| 127 | BHVN | Biohaven Ltd. | 1.40B | 9.77% | 573,166 | - |
| 128 | SVRA | Savara Inc. | 1.38B | 3.43% | 86,817 | - |
| 129 | MNMD | Mind Medicine (MindMed) Inc. | 1.38B | 3.33% | 145,890 | - |
| 130 | CAPR | Capricor Therapeutics, Inc. | 1.37B | 1.03% | 50,348 | 11.13M |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.36B | 3.15% | 31,209 | - |
| 132 | TNGX | Tango Therapeutics, Inc. | 1.36B | 4.14% | 163,387 | 66.50M |
| 133 | IMTX | Immatics N.V. | 1.35B | 4.58% | 113,833 | 99.45M |
| 134 | ORKA | Oruka Therapeutics, Inc. | 1.32B | 2.55% | 36,969 | - |
| 135 | ANAB | AnaptysBio, Inc. | 1.28B | 4.92% | 36,098 | 169.47M |
| 136 | SANA | Sana Biotechnology, Inc. | 1.23B | 5.50% | 472,412 | - |
| 137 | NVAX | Novavax, Inc. | 1.22B | 1.21% | 472,804 | 1.06B |
| 138 | PHAT | Phathom Pharmaceuticals, Inc. | 1.21B | 3.97% | 44,639 | 147.19M |
| 139 | OCS | Oculis Holding AG | 1.21B | - | 39,532 | 992.00K |
| 140 | ERAS | Erasca, Inc. | 1.19B | 15.15% | 2,841,375 | - |
| 141 | ABCL | AbCellera Biologics Inc. | 1.18B | 1.03% | 832,092 | 35.33M |
| 142 | SEPN | Septerna, Inc. | 1.18B | 3.42% | 43,388 | 22.05M |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.18B | 1.94% | 229,631 | 266.14M |
| 144 | NTLA | Intellia Therapeutics, Inc. | 1.17B | 3.91% | 917,161 | 57.53M |
| 145 | INBX | Inhibrx Biosciences, Inc. | 1.15B | 4.14% | 32,941 | 1.40M |
| 146 | PVLA | Palvella Therapeutics, Inc. | 1.14B | 6.82% | 10,053 | - |
| 147 | PHAR | Pharming Group N.V. | 1.14B | 1.19% | 6,335 | 362.27M |
| 148 | NBY | NovaBay Pharmaceuticals, Inc. | 1.12B | 20.16% | 217,208 | 10.30M |
| 149 | SPRY | ARS Pharmaceuticals, Inc. | 1.11B | 0.63% | 141,839 | 142.77M |
| 150 | IOVA | Iovance Biotherapeutics, Inc. | 1.07B | 5.69% | 1,984,062 | 250.43M |
| 151 | URGN | UroGen Pharma Ltd. | 1.07B | 4.39% | 70,777 | 96.52M |
| 152 | CVAC | CureVac N.V. | 1.05B | -0.21% | 1,149,400 | 83.00M |
| 153 | XNCR | Xencor, Inc. | 1.04B | 3.77% | 120,171 | 150.13M |
| 154 | MRVI | Maravai LifeSciences Holdings, Inc. | 989.59M | -0.26% | 54,871 | 192.44M |
| 155 | OMER | Omeros Corporation | 987.64M | 2.96% | 551,350 | - |
| 156 | VTYX | Ventyx Biosciences, Inc. | 981.89M | 36.92% | 9,828,366 | - |
| 157 | NBTX | Nanobiotix S.A. | 971.63M | 1.57% | 13,017 | 11.93M |
| 158 | CMPX | Compass Therapeutics, Inc. | 969.35M | 11.00% | 538,836 | 850.00K |
| 159 | TBPH | Theravance Biopharma, Inc. | 962.78M | 3.83% | 8,632 | 80.33M |
| 160 | ABUS | Arbutus Biopharma Corporation | 957.77M | 3.97% | 269,918 | 14.61M |
| 161 | MDXG | MiMedx Group, Inc. | 944.89M | -0.31% | 56,875 | 393.44M |
| 162 | GHRS | GH Research PLC | 930.44M | 6.23% | 479,673 | - |
| 163 | DAWN | Day One Biopharmaceuticals, Inc. | 925.11M | 4.28% | 151,119 | 133.67M |
| 164 | BCAX | Bicara Therapeutics Inc. | 923.08M | 4.08% | 74,341 | - |
| 165 | ELVN | Enliven Therapeutics, Inc. | 916.92M | 2.05% | 48,705 | - |
| 166 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 916.29M | -1.16% | 45,237 | - |
| 167 | NKTR | Nektar Therapeutics | 910.08M | 4.12% | 78,642 | 62.60M |
| 168 | RAPT | RAPT Therapeutics, Inc. | 902.54M | 5.64% | 9,008 | - |
| 169 | ZBIO | Zenas BioPharma, Inc. | 898.59M | 10.13% | 570,793 | 15.00M |
| 170 | CRMD | CorMedix Inc. | 895.83M | 0.98% | 293,836 | 214.30M |
| 171 | KURA | Kura Oncology, Inc. | 878.88M | 5.87% | 292,629 | 104.03M |
| 172 | IVA | Inventiva S.A. | 875.33M | 7.49% | 218,010 | 19.93M |
| 173 | GERN | Geron Corporation | 864.97M | 2.65% | 835,490 | 183.40M |
| 174 | RIGL | Rigel Pharmaceuticals, Inc. | 864.91M | 10.10% | 108,597 | 282.08M |
| 175 | VIR | Vir Biotechnology, Inc. | 862.58M | 4.03% | 255,525 | 16.86M |
| 176 | VALN | Valneva SE | 846.13M | 0.41% | 3,336 | 211.09M |
| 177 | JANX | Janux Therapeutics, Inc. | 831.24M | 2.83% | 147,890 | 10.00M |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 823.90M | 3.49% | 75,830 | 1.43M |
| 179 | MLTX | MoonLake Immunotherapeutics | 809.02M | 1.48% | 187,119 | - |
| 180 | ANNX | Annexon, Inc. | 808.63M | 6.37% | 273,262 | - |
| 181 | AVBP | ArriVent BioPharma, Inc. | 804.99M | 3.01% | 93,277 | - |
| 182 | ORIC | ORIC Pharmaceuticals, Inc. | 801.03M | 1.04% | 266,760 | - |
| 183 | ARVN | Arvinas, Inc. | 782.89M | 3.04% | 49,658 | 312.30M |
| 184 | YDES | YD Bio Limited | 780.55M | -4.80% | 20,247 | 510.36K |
| 185 | RGNX | REGENXBIO Inc. | 768.96M | 7.12% | 82,327 | 161.32M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 757.38M | 7.97% | 440,712 | 113.63M |
| 187 | ATXS | Astria Therapeutics, Inc. | 754.66M | 2.24% | 62,787 | 706.00K |
| 188 | LXEO | Lexeo Therapeutics, Inc. | 744.47M | 7.26% | 50,391 | - |
| 189 | MPLT | MapLight Therapeutics, Inc. | 742.34M | - | 3,666 | - |
| 190 | PROK | ProKidney Corp. | 715.99M | 5.78% | 272,764 | 744.00K |
| 191 | DRUG | Bright Minds Biosciences Inc. | 705.56M | -13.09% | 40,116 | - |
| 192 | DBVT | DBV Technologies S.A. | 704.68M | 7.64% | 57,226 | 5.50M |
| 193 | REPL | Replimune Group, Inc. | 695.79M | 4.97% | 86,528 | - |
| 194 | PRME | Prime Medicine, Inc. | 693.99M | 5.95% | 960,647 | 5.98M |
| 195 | IVVD | Invivyd, Inc. | 680.34M | 3.15% | 492,361 | 50.04M |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 671.58M | 1.90% | 108,263 | 80.00M |
| 197 | GYRE | Gyre Therapeutics, Inc. | 665.32M | 5.02% | 24,455 | 107.27M |
| 198 | CGEM | Cullinan Therapeutics, Inc. | 656.63M | 9.40% | 130,800 | - |
| 199 | JBIO | Jade Biosciences, Inc. | 648.66M | 7.06% | 24,015 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 629.44M | 4.13% | 22,640 | 27.42M |
| 201 | ABSI | Absci Corporation | 606.00M | 3.33% | 679,994 | 2.82M |
| 202 | GOSS | Gossamer Bio, Inc. | 601.79M | 1.56% | 805,833 | 44.05M |
| 203 | ENGN | enGene Holdings Inc. | 593.48M | 7.26% | 1,094 | - |
| 204 | SLS | SELLAS Life Sciences Group, Inc. | 566.92M | -2.93% | 5,510,935 | - |
| 205 | VSTM | Verastem, Inc. | 561.88M | 5.81% | 114,858 | 13.38M |
| 206 | KROS | Keros Therapeutics, Inc. | 557.53M | 2.87% | 41,079 | 246.72M |
| 207 | LYEL | Lyell Immunopharma, Inc. | 552.34M | 1.05% | 20,093 | 41.00K |
| 208 | DSGN | Design Therapeutics, Inc. | 547.42M | 8.96% | 15,784 | - |
| 209 | LENZ | LENZ Therapeutics, Inc. | 545.70M | 3.50% | 17,305 | 17.50M |
| 210 | NAGE | Niagen Bioscience, Inc. | 542.20M | 0.15% | 80,453 | 124.71M |
| 211 | AUTL | Autolus Therapeutics plc | 540.27M | 1.50% | 352,702 | 51.13M |
| 212 | TENX | Tenax Therapeutics, Inc. | 538.37M | - | 70,793 | - |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.44M | 1.20% | 99,879 | 180.61M |
| 214 | VTVT | vTv Therapeutics Inc. | 521.17M | -1.67% | 107 | 17.00K |
| 215 | CRVS | Corvus Pharmaceuticals, Inc. | 520.53M | 4.34% | 155,012 | - |
| 216 | EVMN | Evommune, Inc. | 513.21M | 1.24% | 46,576 | 13.00M |
| 217 | OCGN | Ocugen, Inc. | 509.08M | 5.84% | 1,171,557 | 5.37M |
| 218 | IMRX | Immuneering Corporation | 504.29M | 16.22% | 1,415,017 | - |
| 219 | VOR | Vor Biopharma Inc. | 501.43M | 10.97% | 329,004 | - |
| 220 | LBRX | LB Pharmaceuticals Inc | 497.13M | -1.21% | 11,655 | - |
| 221 | PRTA | Prothena Corporation plc | 496.47M | 2.82% | 36,802 | 11.79M |
| 222 | ASMB | Assembly Biosciences, Inc. | 493.81M | 2.09% | 12,013 | 37.19M |
| 223 | VNDA | Vanda Pharmaceuticals Inc. | 491.98M | 2.40% | 334,929 | 212.07M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 488.17M | 7.62% | 224,970 | - |
| 225 | PEPG | PepGen Inc. | 487.42M | 3.65% | 107,975 | - |
| 226 | ZVRA | Zevra Therapeutics, Inc. | 482.47M | 3.13% | 157,379 | 84.39M |
| 227 | BCYC | Bicycle Therapeutics plc | 481.41M | 5.63% | 37,274 | 28.34M |
| 228 | ANRO | Alto Neuroscience, Inc. | 481.22M | 2.72% | 33,421 | - |
| 229 | DRTS | Alpha Tau Medical Ltd. | 477.48M | -4.11% | 31,562 | - |
| 230 | ALT | Altimmune, Inc. | 459.54M | 6.31% | 1,647,487 | 20.00K |
| 231 | NBP | NovaBridge Biosciences | 455.98M | 1.93% | 370,664 | - |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 447.08M | 0.76% | 17,250 | - |
| 233 | ADCT | ADC Therapeutics SA | 445.96M | 1.69% | 115,297 | 75.21M |
| 234 | SLDB | Solid Biosciences Inc. | 444.87M | 4.01% | 80,330 | - |
| 235 | LXRX | Lexicon Pharmaceuticals, Inc. | 441.53M | 6.58% | 608,263 | 70.86M |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 436.51M | 6.26% | 69,123 | 120.00K |
| 237 | LCTX | Lineage Cell Therapeutics, Inc. | 436.19M | 5.88% | 336,008 | 10.82M |
| 238 | IMMP | Immutep Limited | 426.65M | 2.38% | 30,893 | 3.31M |
| 239 | FBRX | Forte Biosciences, Inc. | 425.03M | 1.60% | 3,725 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 423.28M | 4.25% | 5,253 | - |
| 241 | MNPR | Monopar Therapeutics Inc. | 423.01M | 3.66% | 82,712 | - |
| 242 | NMRA | Neumora Therapeutics, Inc. | 416.35M | 34.62% | 4,507,377 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 414.49M | 8.19% | 904,902 | - |
| 244 | PRTC | PureTech Health plc | 409.77M | 3.08% | 1,346 | 6.39M |
| 245 | TECX | Tectonic Therapeutic, Inc. | 400.90M | 4.08% | 1,910 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 396.28M | 1.10% | 7,779 | 65.32M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 380.12M | -0.67% | 1,449 | - |
| 248 | TRDA | Entrada Therapeutics, Inc. | 377.44M | 4.41% | 6,602 | 61.52M |
| 249 | AVXL | Anavex Life Sciences Corp. | 367.22M | 2.49% | 145,131 | - |
| 250 | HELP | Cybin Inc. | 361.30M | -2.69% | 79,490 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 351.50M | 1.52% | 24,310 | 33.98M |
| 252 | ACIU | AC Immune SA | 351.25M | 3.50% | 68,780 | 5.48M |
| 253 | ALLO | Allogene Therapeutics, Inc. | 338.22M | 6.74% | 807,384 | 22.00K |
| 254 | AURA | Aura Biosciences, Inc. | 334.66M | 2.13% | 31,799 | - |
| 255 | XOMA | XOMA Royalty Corporation | 330.13M | 0.79% | 294,819 | 47.11M |
| 256 | ZURA | Zura Bio Limited | 329.02M | 4.76% | 79,542 | - |
| 257 | CLLS | Cellectis S.A. | 322.10M | 1.14% | 3,134 | 82.55M |
| 258 | GLSI | Greenwich LifeSciences, Inc. | 314.08M | 10.42% | 105,663 | - |
| 259 | CADL | Candel Therapeutics, Inc. | 312.37M | 1.97% | 143,388 | - |
| 260 | CAMP | Camp4 Therapeutics Corporation | 311.81M | 0.33% | 3,179 | 3.80M |
| 261 | RLMD | Relmada Therapeutics, Inc. | 308.73M | 3.19% | 30,112 | - |
| 262 | AVTX | Avalo Therapeutics, Inc. | 301.57M | 4.56% | 46,621 | 192.00K |
| 263 | NGNE | Neurogene Inc. | 300.97M | 6.17% | 9,873 | 925.00K |
| 264 | TARA | Protara Therapeutics, Inc. | 298.75M | 8.89% | 269,253 | - |
| 265 | LRMR | Larimar Therapeutics, Inc. | 297.85M | 3.26% | 115,467 | - |
| 266 | FHTX | Foghorn Therapeutics Inc. | 297.18M | 6.59% | 14,582 | 24.52M |
| 267 | AARD | Aardvark Therapeutics, Inc. | 295.68M | 2.03% | 13,825 | - |
| 268 | PBYI | Puma Biotechnology, Inc. | 293.28M | -0.68% | 25,184 | 212.00M |
| 269 | MENS | Jyong Biotech Ltd. | 292.23M | 3.83% | 65,010 | - |
| 270 | PALI | Palisade Bio, Inc. | 292.05M | 2.08% | 1,288,353 | - |
| 271 | ACRS | Aclaris Therapeutics, Inc. | 290.37M | 1.13% | 114,669 | 15.74M |
| 272 | ABEO | Abeona Therapeutics Inc. | 281.25M | 0.58% | 121,129 | 400.00K |
| 273 | GUTS | Fractyl Health, Inc. | 280.94M | 2.50% | 456,370 | 3.00K |
| 274 | SLN | Silence Therapeutics plc | 278.68M | 2.97% | 38,610 | 25.83M |
| 275 | STTK | Shattuck Labs, Inc. | 275.27M | 9.30% | 272,810 | 1.00M |
| 276 | ACHV | Achieve Life Sciences, Inc. | 274.16M | 3.21% | 82,110 | - |
| 277 | CTNM | Contineum Therapeutics, Inc. | 273.29M | -1.32% | 19,598 | - |
| 278 | IKT | Inhibikase Therapeutics, Inc. | 270.15M | -1.25% | 24,786 | 1.00 |
| 279 | OABI | OmniAb, Inc. | 267.76M | 1.09% | 28,754 | 21.09M |
| 280 | AVIR | Atea Pharmaceuticals, Inc. | 265.63M | -0.29% | 33,204 | - |
| 281 | IMMX | Immix Biopharma, Inc. | 265.06M | 1.62% | 210,431 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 257.30M | 2.08% | 13,636 | 38.79M |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 254.66M | 1.35% | 21,557 | 2.82M |
| 284 | ALDX | Aldeyra Therapeutics, Inc. | 247.87M | 1.48% | 185,716 | - |
| 285 | NAUT | Nautilus Biotechnology, Inc. | 246.29M | 4.28% | 95,985 | - |
| 286 | MDWD | MediWound Ltd. | 244.89M | 1.65% | 5,817 | 20.93M |
| 287 | PRQR | ProQR Therapeutics N.V. | 237.03M | 8.17% | 173,845 | 18.86M |
| 288 | GALT | Galectin Therapeutics Inc. | 232.75M | 4.64% | 55,588 | - |
| 289 | VYGR | Voyager Therapeutics, Inc. | 230.46M | 3.11% | 44,667 | 31.32M |
| 290 | OVID | Ovid Therapeutics Inc. | 230.43M | 0.57% | 303,483 | 6.61M |
| 291 | HRTX | Heron Therapeutics, Inc. | 228.29M | 2.05% | 91,016 | 155.10M |
| 292 | NVCT | Nuvectis Pharma, Inc. | 225.28M | 7.26% | 17,689 | - |
| 293 | ARMP | Armata Pharmaceuticals, Inc. | 224.27M | 4.94% | 860 | 5.05M |
| 294 | PRLD | Prelude Therapeutics Incorporated | 224.12M | 6.25% | 82,449 | 10.50M |
| 295 | HUMA | Humacyte, Inc. | 223.88M | 7.41% | 2,041,586 | 1.57M |
| 296 | CBIO | Crescent Biopharma, Inc. | 220.72M | 1.99% | 3,731 | - |
| 297 | CCCC | C4 Therapeutics, Inc. | 217.57M | 10.59% | 401,617 | 30.11M |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 213.32M | 2.44% | 1,423,191 | - |
| 299 | EDIT | Editas Medicine, Inc. | 211.83M | 1.40% | 336,307 | 46.38M |
| 300 | CABA | Cabaletta Bio, Inc. | 209.86M | 6.86% | 599,299 | - |
| 301 | CRDF | Cardiff Oncology, Inc. | 206.12M | 3.03% | 397,179 | 501.00K |
| 302 | RZLT | Rezolute, Inc. | 204.93M | 15.71% | 2,591,600 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 197.89M | 8.10% | 19,529 | 1.09M |
| 304 | NERV | Minerva Neurosciences, Inc. | 196.03M | 4.86% | 36,591 | - |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 195.19M | 3.93% | 64,273 | 97.60M |
| 306 | ENLV | Enlivex Therapeutics Ltd. | 192.52M | -0.99% | 59,127 | - |
| 307 | CLYM | Climb Bio, Inc. | 188.11M | 3.41% | 35,922 | - |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 188.10M | -1.17% | 54,973 | 10.30M |
| 309 | ALEC | Alector, Inc. | 185.01M | 0.30% | 216,835 | 69.05M |
| 310 | CHRS | Coherus Oncology, Inc. | 181.91M | 10.66% | 359,708 | 277.73M |
| 311 | TLSA | Tiziana Life Sciences Ltd | 181.80M | 3.38% | 27,631 | - |
| 312 | SABS | SAB Biotherapeutics, Inc. | 181.62M | 5.39% | 46,513 | 114.70K |
| 313 | SGMT | Sagimet Biosciences Inc. | 181.31M | 2.11% | 76,939 | - |
| 314 | NTHI | NeOnc Technologies Holdings, Inc. | 175.17M | 0.73% | 11,117 | 59.99K |
| 315 | RANI | Rani Therapeutics Holdings, Inc. | 172.56M | 2.90% | 208,865 | 1.20M |
| 316 | IPHA | Innate Pharma S.A. | 167.23M | - | 623 | 14.84M |
| 317 | CRBU | Caribou Biosciences, Inc. | 166.37M | 3.49% | 253,788 | 9.30M |
| 318 | QNCX | Quince Therapeutics, Inc. | 164.82M | 6.47% | 20,816 | - |
| 319 | MOLN | Molecular Partners AG | 163.53M | -2.05% | 1,486 | 856.30K |
| 320 | SRZN | Surrozen, Inc. | 161.79M | -4.04% | 1,411 | 3.60M |
| 321 | KLRS | Kalaris Therapeutics, Inc. | 159.81M | 3.45% | 6,727 | - |
| 322 | SGMO | Sangamo Therapeutics, Inc. | 157.48M | 5.38% | 428,054 | 32.88M |
| 323 | CDXS | Codexis, Inc. | 154.45M | -0.58% | 62,931 | 52.93M |
| 324 | BDTX | Black Diamond Therapeutics, Inc. | 154.12M | 4.04% | 151,420 | 70.00M |
| 325 | ACTU | Actuate Therapeutics, Inc. | 153.64M | -0.75% | 18,204 | - |
| 326 | CNTX | Context Therapeutics Inc. | 153.44M | 1.21% | 69,473 | - |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 151.93M | 1.86% | 17,818 | - |
| 328 | CGEN | Compugen Ltd. | 149.66M | 3.23% | 53,179 | 6.90M |
| 329 | ELTX | Elicio Therapeutics, Inc. | 148.36M | 5.20% | 28,107 | - |
| 330 | IRD | Opus Genetics, Inc. | 146.20M | 1.92% | 36,700 | 14.63M |
| 331 | MRSN | Mersana Therapeutics, Inc. | 145.39M | 0.14% | 712,460 | 33.18M |
| 332 | SPRO | Spero Therapeutics, Inc. | 144.79M | 2.39% | 28,671 | 40.55M |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 142.75M | 0.28% | 21,746 | 61.84M |
| 334 | MCRB | Seres Therapeutics, Inc. | 140.31M | -0.26% | 669 | 351.00K |
| 335 | NKTX | Nkarta, Inc. | 139.93M | 2.07% | 93,663 | - |
| 336 | ACOG | Alpha Cognition Inc. | 136.98M | 1.94% | 1,810 | 7.43M |
| 337 | CGTX | Cognition Therapeutics, Inc. | 136.38M | 9.57% | 374,780 | - |
| 338 | KPTI | Karyopharm Therapeutics Inc. | 135.72M | 8.30% | 65,377 | 142.53M |
| 339 | GNLX | Genelux Corporation | 135.43M | 6.19% | 73,622 | 8.00K |
| 340 | TTRX | Turn Therapeutics Inc. | 132.77M | 0.43% | 7,838 | - |
| 341 | ELDN | Eledon Pharmaceuticals, Inc. | 130.01M | 4.22% | 195,904 | - |
| 342 | VRCA | Verrica Pharmaceuticals Inc. | 129.68M | 0.75% | 37,275 | 30.83M |
| 343 | SLGL | Sol-Gel Technologies Ltd. | 128.79M | 0.59% | 935 | 18.97M |
| 344 | FBIO | Fortress Biotech, Inc. | 128.65M | -1.54% | 76,760 | 62.30M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 128.21M | 3.37% | 871,630 | - |
| 346 | ORMP | Oramed Pharmaceuticals Inc. | 128.16M | 4.89% | 115,012 | 2.00M |
| 347 | CNTB | Connect Biopharma Holdings Limited | 126.90M | 0.44% | 7,067 | 762.00K |
| 348 | CBUS | Cibus, Inc. | 126.48M | -0.43% | 71,342 | 3.79M |
| 349 | FATE | Fate Therapeutics, Inc. | 124.00M | 6.44% | 616,132 | 7.14M |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 123.15M | 1.42% | 43,937 | - |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 122.36M | 3.06% | 19,133 | - |
| 352 | WHWK | Whitehawk Therapeutics, Inc. | 120.18M | 1.19% | 2,695 | 14.38M |
| 353 | AGEN | Agenus Inc. | 119.03M | 0.86% | 37,009 | 106.83M |
| 354 | DWTX | Dogwood Therapeutics, Inc. | 118.61M | 0.50% | 10,870 | - |
| 355 | HYFT | MindWalk Holdings Corp. | 116.73M | 7.76% | 156,913 | 19.02M |
| 356 | ZNTL | Zentalis Pharmaceuticals, Inc. | 115.26M | - | 412,253 | 26.87M |
| 357 | MGNX | MacroGenics, Inc. | 113.87M | 5.88% | 342,620 | 127.63M |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 113.02M | 2.81% | 204,884 | 182.34K |
| 359 | COYA | Coya Therapeutics, Inc. | 111.95M | 1.90% | 85,350 | 3.99M |
| 360 | ARTV | Artiva Biotherapeutics, Inc. | 110.45M | 2.04% | 14,921 | 251.00K |
| 361 | RPTX | Repare Therapeutics Inc. | 110.36M | -0.39% | 60,022 | 11.87M |
| 362 | ANIX | Anixa Biosciences, Inc. | 108.95M | 4.09% | 36,561 | - |
| 363 | SAVA | Cassava Sciences, Inc. | 108.45M | 5.90% | 339,433 | - |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 106.75M | 1.61% | 39,898 | 151.93M |
| 365 | THAR | Tharimmune, Inc. | 105.84M | -2.27% | 67,916 | - |
| 366 | ONCY | Oncolytics Biotech Inc. | 105.38M | 1.50% | 23,978 | - |
| 367 | DTIL | Precision BioSciences, Inc. | 104.11M | 2.73% | 44,272 | 698.00K |
| 368 | SEER | Seer, Inc. | 104.07M | 1.09% | 27,342 | 16.38M |
| 369 | ANVS | Annovis Bio, Inc. | 103.10M | 1.04% | 192,276 | - |
| 370 | GANX | Gain Therapeutics, Inc. | 102.69M | 4.71% | 224,720 | - |
| 371 | ACRV | Acrivon Therapeutics, Inc. | 98.77M | 3.99% | 1,028,955 | - |
| 372 | ETHZ | ETHZilla Corporation | 96.19M | -1.55% | 100,461 | 4.11M |
| 373 | STRO | Sutro Biopharma, Inc. | 95.76M | -2.43% | 3,472 | 105.65M |
| 374 | VXRT | Vaxart, Inc. | 95.18M | 1.82% | 18,768 | 148.20M |
| 375 | VANI | Vivani Medical, Inc. | 93.74M | 1.98% | 15,421 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 91.91M | 3.17% | 246,038 | - |
| 377 | IPSC | Century Therapeutics, Inc. | 91.68M | 16.67% | 978,491 | 113.34M |
| 378 | CSBR | Champions Oncology, Inc. | 90.68M | -1.21% | 1,066 | 58.42M |
| 379 | SPRB | Spruce Biosciences, Inc. | 88.78M | 2.94% | 236 | 697.00K |
| 380 | PYXS | Pyxis Oncology, Inc. | 88.42M | 9.23% | 342,336 | 2.82M |
| 381 | PTHS | Pelthos Therapeutics Inc. | 87.97M | 3.86% | 3,014 | 7.41M |
| 382 | ATOS | Atossa Therapeutics, Inc. | 87.72M | 2.83% | 213,264 | - |
| 383 | OKYO | OKYO Pharma Limited | 85.75M | 7.55% | 29,697 | - |
| 384 | EXOZ | eXoZymes, Inc. | 84.71M | -0.39% | 1,125 | -700.00 |
| 385 | ACET | Adicet Bio, Inc. | 83.58M | 2.73% | 5,053 | - |
| 386 | ADAG | Adagene Inc. | 82.48M | -3.85% | 915 | 103.20K |
| 387 | PLRX | Pliant Therapeutics, Inc. | 82.34M | 4.69% | 167,179 | - |
| 388 | CALC | CalciMedica, Inc. | 82.28M | - | 13,884 | - |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 82.24M | 1.52% | 2,977 | 501.00K |
| 390 | EQ | Equillium, Inc. | 82.21M | 4.65% | 96,555 | 4.39M |
| 391 | IFRX | InflaRx N.V. | 81.64M | 2.99% | 128,843 | 73.73K |
| 392 | IMUX | Immunic, Inc. | 80.51M | 7.35% | 600,732 | - |
| 393 | PSTV | Plus Therapeutics, Inc. | 78.88M | 2.32% | 425,713 | 5.26M |
| 394 | KRRO | Korro Bio, Inc. | 78.16M | 0.48% | 70,151 | 7.37M |
| 395 | XBIT | XBiotech Inc. | 76.83M | -0.40% | 18,076 | - |
| 396 | PYPD | PolyPid Ltd. | 76.52M | 0.66% | 3,452 | - |
| 397 | ENTX | Entera Bio Ltd. | 73.37M | 1.91% | 55,549 | 124.00K |
| 398 | ATYR | aTyr Pharma, Inc. | 72.53M | 2.20% | 237,208 | 190.00K |
| 399 | IMA | ImageneBio, Inc. | 71.47M | 1.36% | 153 | 800.00K |
| 400 | KZIA | Kazia Therapeutics Limited | 71.26M | -0.30% | 14,145 | 1.20M |
| 401 | CRVO | CervoMed Inc. | 71.25M | 2.05% | 5,436 | 6.16M |
| 402 | NRXP | NRx Pharmaceuticals, Inc. | 69.57M | -1.67% | 52,493 | 242.00K |
| 403 | TVGN | Tevogen Bio Holdings Inc. | 69.30M | -0.09% | 64,483 | - |
| 404 | MNOV | MediciNova, Inc. | 68.80M | 1.45% | 6,512 | 257.92K |
| 405 | TCRX | TScan Therapeutics, Inc. | 67.81M | 4.82% | 168,654 | 8.42M |
| 406 | MGX | Metagenomi, Inc. | 66.83M | 2.30% | 57,323 | 30.91M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 65.98M | 1.64% | 3,443 | - |
| 408 | ATHE | Alterity Therapeutics Limited | 65.90M | 0.31% | 263 | 3.57M |
| 409 | ALXO | ALX Oncology Holdings Inc. | 64.52M | 10.19% | 7,988 | - |
| 410 | MREO | Mereo BioPharma Group plc | 63.83M | 5.83% | 4,690,619 | 500.00K |
| 411 | BYSI | BeyondSpring Inc. | 60.86M | -1.33% | 29,253 | 1.88M |
| 412 | PASG | Passage Bio, Inc. | 59.76M | 1.84% | 33,982 | - |
| 413 | ICCC | ImmuCell Corporation | 58.89M | 2.52% | 394 | 27.77M |
| 414 | MAIA | MAIA Biotechnology, Inc. | 58.54M | -0.01% | 31,306 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 58.40M | 3.32% | 3,763 | - |
| 416 | GRCE | Grace Therapeutics, Inc. | 58.03M | 3.31% | 4,578 | - |
| 417 | ALGS | Aligos Therapeutics, Inc. | 57.97M | 7.53% | 11,533 | 2.65M |
| 418 | RADX | Radiopharm Theranostics Limited | 57.27M | 2.50% | 12,856 | 8.20M |
| 419 | ANL | Adlai Nortye Ltd. | 56.09M | 4.11% | 35,593 | -1.35M |
| 420 | ESLA | Estrella Immunopharma, Inc. | 55.14M | 6.57% | 10,465 | - |
| 421 | JSPR | Jasper Therapeutics, Inc. | 55.13M | 3.68% | 140,054 | - |
| 422 | IBO | Impact BioMedical Inc. | 54.95M | -0.91% | 3,765 | 25.00K |
| 423 | NTRB | Nutriband Inc. | 54.70M | 2.04% | 2,624 | 2.28M |
| 424 | LITS | Lite Strategy, Inc. | 54.44M | -3.90% | 40,854 | - |
| 425 | ABVC | ABVC BioPharma, Inc. | 54.21M | 1.32% | 17,650 | 797.92K |
| 426 | CVM | CEL-SCI Corporation | 53.10M | 0.40% | 8,325 | - |
| 427 | OSTX | OS Therapies Incorporated | 53.00M | 1.69% | 102,440 | - |
| 428 | PDSB | PDS Biotechnology Corporation | 52.53M | 5.77% | 120,805 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 49.51M | -0.69% | 21,158 | - |
| 430 | IOBT | IO Biotech, Inc. | 48.91M | 6.32% | 121,655 | - |
| 431 | NRXS | NeurAxis, Inc. | 47.94M | 0.90% | 15,164 | 3.36M |
| 432 | ANEB | Anebulo Pharmaceuticals, Inc. | 47.25M | -0.86% | 4,835 | - |
| 433 | PTN | Palatin Technologies, Inc. | 47.18M | -0.43% | 5,270 | 8.85M |
| 434 | TIL | Instil Bio, Inc. | 47.13M | 4.35% | 305,752 | - |
| 435 | IBIO | iBio, Inc. | 47.00M | 1.46% | 931,014 | 500.00K |
| 436 | NXTC | NextCure, Inc. | 46.17M | 1.39% | 357 | - |
| 437 | KZR | Kezar Life Sciences, Inc. | 46.14M | 0.80% | 7,069 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 45.86M | 2.80% | 2,715 | 90.00K |
| 439 | APLM | Apollomics, Inc. | 45.07M | 3.71% | 5,208 | 6.93M |
| 440 | HURA | TuHURA Biosciences, Inc. | 43.72M | -0.80% | 42,172 | - |
| 441 | INMB | INmune Bio, Inc. | 42.40M | 2.24% | 23,875 | 50.00K |
| 442 | EVAX | Evaxion A/S | 42.28M | 0.40% | 12,952 | 7.65M |
| 443 | LPCN | Lipocine Inc. | 42.22M | 1.20% | 12,556 | 4.32M |
| 444 | QTTB | Q32 Bio Inc. | 41.34M | -0.30% | 34,276 | - |
| 445 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.73M | 5.23% | 898,942 | - |
| 446 | LTRN | Lantern Pharma Inc. | 38.36M | -0.58% | 10,274 | - |
| 447 | XCUR | Exicure, Inc. | 38.24M | 1.87% | 8,801 | 500.00K |
| 448 | OKUR | OnKure Therapeutics, Inc. | 37.93M | 0.72% | 429 | - |
| 449 | FGEN | FibroGen, Inc. | 37.85M | 3.71% | 5,072 | 8.30M |
| 450 | RNXT | RenovoRx, Inc. | 37.75M | 0.98% | 44,693 | 928.00K |
| 451 | VERU | Veru Inc. | 37.40M | - | 9,750 | 16.89M |
| 452 | CUE | Cue Biopharma, Inc. | 36.89M | 10.13% | 221,957 | 7.10M |
| 453 | XLO | Xilio Therapeutics, Inc. | 36.77M | 0.75% | 22,061 | 31.80M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 36.59M | -0.76% | 13,455 | - |
| 455 | GBIO | Generation Bio Co. | 36.38M | 0.36% | 1,284 | 15.27M |
| 456 | OTLK | Outlook Therapeutics, Inc. | 36.12M | 6.40% | 1,883,017 | 1.41M |
| 457 | JUNS | Jupiter Neurosciences, Inc. | 35.80M | -1.42% | 12,343 | - |
| 458 | SKYE | Skye Bioscience, Inc. | 35.58M | 9.90% | 252,007 | - |
| 459 | CELU | Celularity Inc. | 35.03M | -1.60% | 2,117 | 40.58M |
| 460 | GLTO | Galecto, Inc. | 34.84M | - | 6,678 | - |
| 461 | DYAI | Dyadic International, Inc. | 33.65M | - | 36 | 3.34M |
| 462 | GNTA | Genenta Science S.p.A. | 33.27M | -0.70% | 14,116 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 33.18M | 6.99% | 201,387 | 4.69M |
| 464 | RNTX | Rein Therapeutics Inc. | 32.33M | 0.82% | 4,812 | - |
| 465 | HOWL | Werewolf Therapeutics, Inc. | 32.03M | 2.74% | 18,540 | 1.14M |
| 466 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.97M | 3.09% | 14,019 | - |
| 467 | CING | Cingulate Inc. | 31.76M | 0.43% | 12,596 | - |
| 468 | HYPD | Hyperion DeFi, Inc. | 30.57M | -2.86% | 14,503 | 345.32K |
| 469 | ANTX | AN2 Therapeutics, Inc. | 30.14M | 2.80% | 56 | - |
| 470 | SNTI | Senti Biosciences, Inc. | 29.97M | 3.64% | 16,540 | - |
| 471 | BRNS | Barinthus Biotherapeutics plc | 29.81M | 2.80% | 13 | 14.97M |
| 472 | RLYB | Rallybio Corporation | 29.71M | 3.61% | 21,845 | 674.00K |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 29.68M | 4.14% | 414,380 | 721.00K |
| 474 | DARE | Daré Bioscience, Inc. | 28.29M | 1.02% | 2,213 | -57.13K |
| 475 | ATHA | Athira Pharma, Inc. | 28.00M | 2.16% | 2,480 | - |
| 476 | BOLD | Boundless Bio, Inc. | 27.76M | 0.81% | 10,792 | - |
| 477 | IGC | IGC Pharma, Inc. | 27.67M | 3.11% | 146,060 | 1.11M |
| 478 | PLUR | Pluri Inc. | 27.22M | 1.03% | 4,025 | 1.33M |
| 479 | QNTM | Quantum BioPharma Ltd. | 26.99M | 0.57% | 8,203 | - |
| 480 | BCAB | BioAtla, Inc. | 26.67M | 4.95% | 252,914 | 11.00M |
| 481 | PLRZ | Polyrizon Ltd. | 26.55M | 1.28% | 2,095 | - |
| 482 | NRSN | NeuroSense Therapeutics Ltd. | 25.26M | -2.37% | 30,577 | - |
| 483 | NNVC | NanoViricides, Inc. | 24.60M | -1.56% | 15,629 | - |
| 484 | INTS | Intensity Therapeutics, Inc. | 23.87M | 0.61% | 146,225 | - |
| 485 | KLTO | Klotho Neurosciences, Inc. | 23.28M | -1.65% | 23,724 | - |
| 486 | SER | Serina Therapeutics, Inc. | 23.25M | 4.80% | 1,390 | 116.00K |
| 487 | KTTA | Pasithea Therapeutics Corp. | 22.62M | -6.48% | 173,801 | - |
| 488 | LNAI | Lunai Bioworks Inc. | 21.61M | 0.26% | 6,526 | - |
| 489 | NEUP | Neuphoria Therapeutics Inc. | 21.40M | - | 1,020 | 15.65M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 19.68M | -3.30% | 36,666 | - |
| 491 | LIMN | Liminatus Pharma, Inc. | 19.59M | 8.86% | 34,556 | - |
| 492 | ALLR | Allarity Therapeutics, Inc. | 19.19M | -0.45% | 25,597 | - |
| 493 | ITRM | Iterum Therapeutics plc | 19.04M | 2.97% | 20,631 | 390.00K |
| 494 | CLGN | CollPlant Biotechnologies Ltd. | 18.53M | - | - | 2.48M |
| 495 | MTVA | MetaVia Inc. | 18.49M | 3.70% | 1,733 | - |
| 496 | VYNE | VYNE Therapeutics Inc. | 18.48M | 0.29% | 128,428 | 524.00K |
| 497 | FBLG | FibroBiologics, Inc. | 18.36M | 6.15% | 410,666 | - |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 17.54M | 8.23% | 10,325 | - |
| 499 | CASI | CASI Pharmaceuticals, Inc. | 17.40M | -0.40% | 2,535 | 26.85M |
| 500 | LSTA | Lisata Therapeutics, Inc. | 17.20M | - | 7,736 | 1.07M |
| 501 | LEXX | Lexaria Bioscience Corp. | 16.87M | -3.31% | 23,393 | 705.92K |
| 502 | KAPA | Kairos Pharma, Ltd. | 16.87M | 2.40% | 4,639 | - |
| 503 | PMN | ProMIS Neurosciences, Inc. | 16.62M | 0.39% | 343 | - |
| 504 | GRDX | GridAI Technologies Corp. | 16.37M | 5.87% | 69,444 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 16.29M | 0.97% | 17,914 | - |
| 506 | GDTC | CytoMed Therapeutics Limited | 16.04M | - | 14 | 573.19K |
| 507 | OSRH | OSR Holdings, Inc. | 15.49M | 0.55% | 24,478 | -90.52K |
| 508 | NCNA | NuCana plc | 15.19M | -1.35% | 11,618 | - |
| 509 | COCP | Cocrystal Pharma, Inc. | 15.16M | 0.46% | 10,128 | - |
| 510 | APLT | Applied Therapeutics, Inc. | 15.14M | -1.04% | 700,726 | 1.00M |
| 511 | ASBP | Aspire Biopharma Holdings, Inc. | 15.05M | 33.33% | 354,863,509 | 1.94K |
| 512 | SNGX | Soligenix, Inc. | 14.50M | 1.99% | 14,767 | 2.34K |
| 513 | AEON | AEON Biopharma, Inc. | 14.44M | -1.61% | 17,223 | - |
| 514 | KALA | KALA BIO, Inc. | 14.31M | -6.53% | 431,922 | - |
| 515 | CLRB | Cellectar Biosciences, Inc. | 14.03M | 2.80% | 1,183 | - |
| 516 | SYBX | Synlogic, Inc. | 13.92M | - | 6,926 | 8.00K |
| 517 | TPST | Tempest Therapeutics, Inc. | 13.85M | -0.35% | 25,969 | - |
| 518 | ABP | Abpro Holdings, Inc. | 13.74M | 4.33% | 3,596 | 183.00K |
| 519 | AKTX | Akari Therapeutics, Plc | 13.74M | 3.48% | 18,315 | - |
| 520 | BCTX | BriaCell Therapeutics Corp. | 13.44M | -1.05% | 12,800 | - |
| 521 | BCDA | BioCardia, Inc. | 13.37M | -0.80% | 5,953 | 3.00K |
| 522 | SNSE | Sensei Biotherapeutics, Inc. | 13.32M | -2.94% | 3,176 | - |
| 523 | BLRX | BioLineRx Ltd. | 13.18M | -0.17% | 938 | 12.74M |
| 524 | MBRX | Moleculin Biotech, Inc. | 12.70M | 0.12% | 35,389 | - |
| 525 | EDSA | Edesa Biotech, Inc. | 12.42M | - | 4,379 | - |
| 526 | IMNN | Imunon, Inc. | 12.40M | 2.28% | 4,888 | - |
| 527 | LGVN | Longeveron Inc. | 12.35M | -1.30% | 31,711 | 1.44M |
| 528 | PHIO | Phio Pharmaceuticals Corp. | 12.22M | -1.27% | 46,031 | - |
| 529 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.87M | 1.58% | 2,872 | - |
| 530 | BOLT | Bolt Biotherapeutics, Inc. | 11.48M | 1.68% | 588 | 5.20M |
| 531 | CMMB | Chemomab Therapeutics Ltd. | 11.28M | 1.26% | 2,766 | - |
| 532 | INAB | IN8bio, Inc. | 11.12M | -2.83% | 11,790 | - |
| 533 | BIVI | BioVie Inc. | 10.69M | 2.01% | 12,334 | - |
| 534 | NCEL | NewcelX Ltd. | 10.60M | -0.21% | 9,340 | - |
| 535 | TRAW | Traws Pharma, Inc. | 10.51M | 1.15% | 6,575 | 2.85M |
| 536 | CRIS | Curis, Inc. | 10.50M | -18.80% | 12,352,698 | 11.65M |
| 537 | BRTX | BioRestorative Therapies, Inc. | 10.39M | - | 3,005 | 383.40K |
| 538 | EVGN | Evogene Ltd. | 9.91M | - | 27,436 | 8.02M |
| 539 | ERNA | Ernexa Therapeutics Inc. | 9.81M | -1.57% | 79,261 | 1,000.00 |
| 540 | ICU | SeaStar Medical Holding Corporation | 9.57M | - | 13,065 | 881.00K |
| 541 | GOVX | GeoVax Labs, Inc. | 8.90M | -4.69% | 546,812 | 3.35M |
| 542 | APM | Aptorum Group Limited | 8.76M | 2.48% | 2,781 | - |
| 543 | CLDI | Calidi Biotherapeutics, Inc. | 8.56M | 1.75% | 11,708 | - |
| 544 | PULM | Pulmatrix, Inc. | 8.40M | - | 1,493 | 3.00K |
| 545 | GTBP | GT Biopharma, Inc. | 8.31M | -1.57% | 91,836 | - |
| 546 | CELZ | Creative Medical Technology Holdings, Inc. | 8.25M | 5.83% | 7,795 | 6.00K |
| 547 | ALZN | Alzamend Neuro, Inc. | 8.14M | 0.47% | 38,317 | - |
| 548 | TOVX | Theriva Biologics, Inc. | 8.10M | -1.07% | 579,891 | - |
| 549 | KPRX | Kiora Pharmaceuticals, Inc. | 7.96M | 2.36% | 1,604 | 20.00K |
| 550 | MBIO | Mustang Bio, Inc. | 7.96M | - | 5,414 | - |
| 551 | PMCB | PharmaCyte Biotech, Inc. | 7.85M | 0.39% | 18,526 | - |
| 552 | PCSA | Processa Pharmaceuticals, Inc. | 7.82M | 2.07% | 17,757 | - |
| 553 | APVO | Aptevo Therapeutics Inc. | 7.77M | 4.40% | 13,059 | - |
| 554 | ADXN | Addex Therapeutics Ltd | 7.68M | 3.46% | 993 | 198.82K |
| 555 | IMRN | Immuron Limited | 7.67M | 8.78% | 9,315 | 4.78M |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 7.19M | 0.63% | 1,936 | 6.00K |
| 557 | PPBT | Purple Biotech Ltd | 7.04M | -0.14% | 52,272 | - |
| 558 | PPCB | Propanc Biopharma, Inc. | 6.95M | 2.63% | 7,527 | - |
| 559 | XTLB | XTL Biopharmaceuticals Ltd. | 6.87M | - | 729 | 968.00K |
| 560 | ACXP | Acurx Pharmaceuticals, Inc. | 6.78M | 11.30% | 31,432 | - |
| 561 | CYCN | Cyclerion Therapeutics, Inc. | 6.74M | -9.23% | 962,786 | 2.86M |
| 562 | SLXN | Silexion Therapeutics Corp | 6.72M | 1.90% | 1,856 | - |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 6.72M | 2.27% | 60,381 | - |
| 564 | RNAZ | TransCode Therapeutics, Inc. | 6.71M | -0.54% | 9,584 | - |
| 565 | BGMS | Bio Green Med Solution, Inc. | 6.57M | -1.47% | 5,359 | 81.00K |
| 566 | LYRA | Lyra Therapeutics, Inc. | 6.39M | 7.14% | 7,061 | 600.00K |
| 567 | APRE | Aprea Therapeutics, Inc. | 5.68M | -1.32% | 7,331 | 488.24K |
| 568 | CANF | Can-Fite BioPharma Ltd. | 5.52M | - | 32,814 | 560.00K |
| 569 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.48M | 1.52% | 18,402,748 | 15.78K |
| 570 | VIVS | VivoSim Labs, Inc. | 5.40M | 1.47% | 2,561 | 140.00K |
| 571 | REVB | Revelation Biosciences, Inc. | 5.39M | -1.13% | 106,102 | - |
| 572 | JAGX | Jaguar Health, Inc. | 5.04M | -1.77% | 21,060 | 11.79M |
| 573 | SILO | Silo Pharma, Inc. | 5.00M | -1.19% | 28,978 | 72.10K |
| 574 | XBIO | Xenetic Biosciences, Inc. | 4.90M | 1.09% | 418 | 2.86M |
| 575 | SPRC | SciSparc Ltd. | 4.88M | 1.36% | 8,266 | 1.31M |
| 576 | SLRX | Salarius Pharmaceuticals, Inc. | 4.84M | 16.71% | 3,844,880 | - |
| 577 | GNPX | Genprex, Inc. | 4.57M | 4.23% | 629,719 | - |
| 578 | GLMD | Galmed Pharmaceuticals Ltd. | 4.55M | 0.94% | 36,958 | - |
| 579 | INDP | Indaptus Therapeutics, Inc. | 4.43M | -2.32% | 13,062 | - |
| 580 | ENVB | Enveric Biosciences, Inc. | 4.26M | 2.97% | 2,908 | - |
| 581 | XRTX | XORTX Therapeutics Inc. | 4.06M | -0.15% | 16,004 | - |
| 582 | MTNB | Matinas BioPharma Holdings, Inc. | 4.02M | 4.90% | 2,439 | - |
| 583 | CMND | Clearmind Medicine Inc. | 3.97M | -1.67% | 10,818 | - |
| 584 | OGEN | Oragenics, Inc. | 3.70M | 1.93% | 1,789 | - |
| 585 | ENSC | Ensysce Biosciences, Inc. | 3.63M | -0.99% | 9,744 | 4.49M |
| 586 | PHGE | BiomX Inc. | 3.39M | - | 4,421 | - |
| 587 | HCWB | HCW Biologics Inc. | 3.35M | 3.33% | 7,729 | 422.03K |
| 588 | CNSP | CNS Pharmaceuticals, Inc. | 3.29M | - | 33 | - |
| 589 | AZTR | Azitra, Inc. | 3.24M | 6.15% | 9,407 | 7.50K |
| 590 | GRI | GRI Bio, Inc. | 3.05M | -0.10% | 175,998 | - |
| 591 | ONCO | Onconetix, Inc. | 2.82M | 3.71% | 2,401 | 1.22M |
| 592 | BBLG | Bone Biologics Corporation | 2.81M | 0.97% | 7,445 | - |
| 593 | VRAX | Virax Biolabs Group Limited | 2.77M | 0.31% | 86,504 | 2.99K |
| 594 | ARTL | Artelo Biosciences, Inc. | 2.68M | 1.53% | 556 | - |
| 595 | SCNI | Scinai Immunotherapeutics Ltd. | 2.61M | -0.80% | 1,937 | 1.15M |
| 596 | DRMA | Dermata Therapeutics, Inc. | 2.59M | -2.64% | 27,806 | - |
| 597 | CDT | CDT Equity Inc. | 2.48M | 0.66% | 10,705 | - |
| 598 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.18M | -0.01% | 85,495 | 1.36M |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 1.99M | -3.27% | 27,572 | 104.90K |
| 600 | ADTX | Aditxt, Inc. | 1.57M | 0.22% | 69,704 | 5.95K |
| 601 | PBM | Psyence Biomedical Ltd. | 1.43M | 3.99% | 124,242 | - |
| 602 | ELAB | PMGC Holdings Inc. | 1.06M | 1.42% | 44,325 | 285.95K |
| 603 | MLEC | Moolec Science SA | 1.03M | - | 2,737 | 7.83M |